Human IPS cell generation using episomal vector

Ended Purchase Order Awarded Last action

Contract number
75N92021P00169
Awardee
Awarding agency
Obligated
$19,900

Award facts

Opportunity
Contract value 100% obligated
$19,900.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
San Pablo, CA, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00003 -$29,900
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $49,800

About this award

The National Heart Lung and Blood Institute awarded a purchase order to Alstem, Inc. valued at $19,900.00 on May 21, 2021, for human induced pluripotent stem cell generation using episomal vector technology. Performance is located in San Pablo, California. The order is firm fixed price with no set-aside applied. Work is due for completion by June 30, 2022. The solicitation was posted May 5, 2021, with a due date of May 19, 2021.

Quick answers

Who was awarded contract 75N92021P00169?

75N92021P00169 was awarded to Alstem, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on May 21, 2021.

How much is contract 75N92021P00169 worth?

The government has obligated $19,900 on 75N92021P00169.

Was contract 75N92021P00169 competed?

The extent of competition for 75N92021P00169 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award